DeutschNewstral
Article
The Economist on 2021-04-15 23:15
In clinical and real world trials, China’s Sinovac underperforms
Related news
- HTurkey says China’s Sinovac COVID Vaccine 91.25% Effective in Late Trialshamodia.com
Brazil Suspends Trials of China’s Sinovac Coronavirus Vaccinewsj.com
Brazil suspends clinical trials for China’s coronavirus vaccineisraelnationalnews.com
Covid-19: China’s Sinopharm mRNA vaccine approved for clinical trialsSouth China Morning Post- Domestic clinical trials planned for China’s mRNA Covid-19 vaccineSouth China Morning Post
China’s first coronavirus vaccine approved for clinical trialsNew York Post
China’s Sinovac COVID-19 vaccine induces quick antibody responses: studyherald.co.zw- China’s Sinovac Covid-19 Vaccine Is 50.4% Effective in Late-Stage Brazil Trialswsj.com
Indonesia’s top Islamic body OKs China’s Sinovac vaccineSeattle Times- China’s promising pancreatic cancer treatment to start clinical trials after showing ‘superior efficacy’South China Morning Post
JPM2024: Impact of China’s HGR Rules on clinical trials and scientific studies involving China sitesjdsupra.com
China’s Sinovac vaccine efficacy 83.5 percent: Turkish researchersHurriyet Daily News
Brazil suspends trials of China's Sinovac coronavirus vaccine, citing 'serious adverse event'CNN
China begins clinical trials for new ARV to treat coronavirusvanguardngr.com- COVID-19 vaccines now in phase 3 clinical trials — WHOvanguardngr.com
- Sinovac outpaces Western jabs in trialsherald.co.zw
- Coronavirus latest: India nears 3 million cases; Indonesia and China’s Sinovac sign vaccine dealSouth China Morning Post
- BBusinessinsider.co.za | WHO approves China’s Sinovac jab – but SA’s regulator is still silent after 2 monthsbusinessinsider.co.za
- Coronavirus: Brazil reports more modest 50.4 per cent efficacy for China’s Sinovac vaccineSouth China Morning Post